David Charles Vajnar, MD General Practice Medicare: Not Enrolled in Medicare Practice Location: 340 Webb Smith Dr, Colfax, LA 71417 Phone: 318-627-5021 Fax: 318-627-5999 |
News Archive
CTG, an international information technology (IT) solutions and services company, announced today that CTG HealthCare Solutions (CTGHS), its business unit serving healthcare providers, was named by Modern Healthcare to its annual ranking of the 15 largest healthcare management consulting firms.
Data presented at the 73rd Annual Scientific Meeting of the American College of Rheumatology highlight effects of baseline characteristics on achievement of serum uric acid (sUA) levels to <6.0 mg/dL and the frequency of flares with ULORIC- (febuxostat) treatment.
A new study by researchers at Children's Hospital Los Angeles has shown that neonatal mouse hearts have varying regenerative capacities depending upon the severity of injury. Using cryoinjury - damaging the heart through exposure to extreme cold in order to mimic cellular injury caused by myocardial infarction - investigators found that neonatal mouse hearts can fully recover normal function following a mild injury, though fail to regenerate after a severe injury.
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that its tumor-targeting pro-drug candidate INNO-206 has been approved for orphan drug designation for the treatment of patients with pancreatic cancer by the Office of Orphan Products Development of the U.S. Food and Drug Administration (FDA). CytRx holds the exclusive worldwide development and commercialization rights to INNO-206.
› Verified 9 days ago